ID29241A - Turunan-turunan kinolin teranelasi-1,2 - Google Patents
Turunan-turunan kinolin teranelasi-1,2Info
- Publication number
- ID29241A ID29241A IDW00200101373A ID20011373A ID29241A ID 29241 A ID29241 A ID 29241A ID W00200101373 A IDW00200101373 A ID W00200101373A ID 20011373 A ID20011373 A ID 20011373A ID 29241 A ID29241 A ID 29241A
- Authority
- ID
- Indonesia
- Prior art keywords
- teranelasi
- kinolin
- districts
- teranelasi kinolin
- kinolin districts
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/498—Pyrazines or piperazines ortho- and peri-condensed with carbocyclic ring systems, e.g. quinoxaline, phenazine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Quinoline Compounds (AREA)
- Processing And Handling Of Plastics And Other Materials For Molding In General (AREA)
- Information Retrieval, Db Structures And Fs Structures Therefor (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP98204444 | 1998-12-23 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ID29241A true ID29241A (id) | 2001-08-16 |
Family
ID=8234557
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IDW00200101373A ID29241A (id) | 1998-12-23 | 1999-12-17 | Turunan-turunan kinolin teranelasi-1,2 |
Country Status (32)
| Country | Link |
|---|---|
| US (2) | US6458800B1 (cs) |
| EP (1) | EP1140935B1 (cs) |
| JP (1) | JP4725940B2 (cs) |
| KR (2) | KR100712226B1 (cs) |
| CN (1) | CN1178938C (cs) |
| AR (1) | AR021995A1 (cs) |
| AT (1) | ATE240327T1 (cs) |
| AU (1) | AU765437B2 (cs) |
| BG (1) | BG65124B1 (cs) |
| BR (1) | BR9916827A (cs) |
| CA (1) | CA2355717C (cs) |
| CZ (1) | CZ302374B6 (cs) |
| DE (1) | DE69907964T2 (cs) |
| DK (1) | DK1140935T3 (cs) |
| EA (1) | EA004542B1 (cs) |
| EE (1) | EE04962B1 (cs) |
| ES (1) | ES2200591T3 (cs) |
| HK (1) | HK1038746B (cs) |
| HR (1) | HRP20010454B1 (cs) |
| HU (1) | HU229404B1 (cs) |
| ID (1) | ID29241A (cs) |
| IL (2) | IL143859A0 (cs) |
| NO (1) | NO318922B1 (cs) |
| PL (1) | PL199080B1 (cs) |
| PT (1) | PT1140935E (cs) |
| SI (1) | SI1140935T1 (cs) |
| SK (1) | SK286072B6 (cs) |
| TR (1) | TR200101961T2 (cs) |
| TW (1) | TW531533B (cs) |
| UA (1) | UA71592C2 (cs) |
| WO (1) | WO2000039082A2 (cs) |
| ZA (1) | ZA200105136B (cs) |
Families Citing this family (67)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2396865C (en) * | 2000-02-04 | 2009-04-14 | Janssen Pharmaceutica N.V. | Farnesyl protein transferase inhibitors for treating breast cancer |
| US6838467B2 (en) | 2000-02-24 | 2005-01-04 | Janssen Pharmaceutica N. V. | Dosing regimen |
| EP1261348A2 (en) * | 2000-02-29 | 2002-12-04 | Janssen Pharmaceutica N.V. | Combinations of a farnesyl protein transferase inhibitor with nitrogen mustard or nitrosourea alkylating agents |
| WO2001064246A2 (en) * | 2000-02-29 | 2001-09-07 | Janssen Pharmaceutica N.V. | Farnesyl protein transferase inhibitor combinations with an her2 antibody |
| CA2397475A1 (en) * | 2000-02-29 | 2001-09-07 | Janssen Pharmaceutica N.V. | Farnesyl protein transferase inhibitor combinations with vinca alkaloids |
| WO2001064226A2 (en) * | 2000-02-29 | 2001-09-07 | Janssen Pharmaceutica N.V. | Farnesyl protein transferase inhibitor combinations with platinum compounds |
| AU2001244166A1 (en) * | 2000-02-29 | 2001-09-12 | Janssen Pharmaceutica N.V. | Farnesyl protein transferase inhibitor combinations with further anti-cancer agents |
| CA2397694A1 (en) * | 2000-02-29 | 2001-09-07 | Janssen Pharmaceutica Inc. | Farnesyl protein transferase inhibitor combinations |
| AU2001246478A1 (en) * | 2000-02-29 | 2001-09-12 | Janssen Pharmaceutica N.V. | Farnesyl protein transferase inhibitor combinations with taxane compounds |
| EP1267872A2 (en) * | 2000-02-29 | 2003-01-02 | Janssen Pharmaceutica N.V. | Farnesyl protein transferase inhibitor combinations with anti-tumor anthracycline derivatives |
| CA2397256A1 (en) * | 2000-02-29 | 2001-09-07 | Mary Ellen Margaret Rybak | Farnesyl protein transferase inhibitor combinations with anti-tumor podophyllotoxin derivatives |
| AU2001256166A1 (en) * | 2000-02-29 | 2001-09-12 | Janssen Pharmaceutica N.V. | Farnesyl protein transferase inhibitor combinations with anti-tumor nucleoside derivatives |
| JP2003525234A (ja) * | 2000-02-29 | 2003-08-26 | ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ | カンプトテシン化合物とのファルネシルタンパク質トランスフェラーゼ阻害剤の組み合わせ剤 |
| JO2361B1 (en) | 2000-06-22 | 2006-12-12 | جانسين فارماسيوتيكا ان. في | Enaniumer 1,2-anylated quinoline inhibitor for the transporter - farnesyl |
| EP1322644A1 (en) * | 2000-09-25 | 2003-07-02 | Janssen Pharmaceutica N.V. | Farnesyl transferase inhibiting 6-heterocyclylmethyl quinolinone derivatives |
| EP1322636A1 (en) | 2000-09-25 | 2003-07-02 | Janssen Pharmaceutica N.V. | Farnesyl transferase inhibiting 6- (substituted phenyl)methyl]-quinoline and quinazoline derivatives |
| AU2001293826A1 (en) * | 2000-09-25 | 2002-04-02 | Janssen Pharmaceutica N.V. | Farnesyl transferase inhibiting quinoline and quinazoline derivatives as farnesyl transferase inhibitors |
| JP4974438B2 (ja) * | 2000-09-25 | 2012-07-11 | ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ | ファルネシルトランスフェラーゼを阻害する６−ヘテロシクリルメチルキノリンおよびキナゾリン誘導体 |
| EA007464B1 (ru) * | 2000-10-02 | 2006-10-27 | Янссен Фармацевтика Н.В. | Антагонисты метаботропных рецепторов глутамата |
| DE60139080D1 (de) * | 2000-11-21 | 2009-08-06 | Janssen Pharmaceutica Nv | Farnesyltransferase hemmende benzoheterocyclische derivate |
| JP4231691B2 (ja) * | 2000-11-28 | 2009-03-04 | ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ | 炎症性腸疾患の治療のためのファルネシルタンパク質トランスフェラーゼ阻害剤 |
| DE60117847T2 (de) | 2000-12-27 | 2006-11-16 | Janssen Pharmaceutica N.V. | Farnesyltransferase hemmende, in der 4-stellung substituierte chinolin- und chinazolinderivate |
| ATE415161T1 (de) * | 2001-02-15 | 2008-12-15 | Janssen Pharmaceutica Nv | Farnesyl-protein-transferase hemmer in kombination mit antiöstrogenen |
| US20040157773A1 (en) * | 2001-04-25 | 2004-08-12 | End David William | Farnesyl protein transferase inhibitors for treating cachexia |
| US6740757B2 (en) * | 2001-08-29 | 2004-05-25 | Pfizer Inc | Enantiomers of 6-[(4-chloro-phenyl)-hydroxy-(3-methyl-3h-imidazol-4-yl)-methyl]-4-[3-(3-hydroxy-3-methyl-but-1-ynyl)-phenyl]-1-methyl-1h-quinolin-2-one and salts thereof, useful in the treatment of cancer |
| CA2468015A1 (en) * | 2001-11-27 | 2003-06-05 | Merck & Co., Inc. | 2-aminoquinoline compounds |
| AU2002358677B2 (en) | 2001-12-19 | 2008-02-07 | Janssen Pharmaceutica N.V. | 1,8-annelated quinoline derivatives substituted with carbon-linked triazoles as farnesyl transferase inhibitors |
| EP1490065B1 (en) | 2002-03-22 | 2007-06-13 | Janssen Pharmaceutica N.V. | Benzylimidazolyl substituted 2-quinolinone and quinazolinone derivatives for use as farnesyl transferase inhibitors |
| BR0308945A (pt) * | 2002-03-29 | 2005-01-04 | Janssen Pharmaceutica Nv | Derivados radiomarcados de quinolina e quinolinona e uso dos mesmos como ligantes para receptores de glutamato metabotrópicos |
| JP4384505B2 (ja) * | 2002-04-15 | 2009-12-16 | ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ | ファルネシルトランスフェラーゼを阻害する炭素連結イミダゾールもしくはトリアゾール置換三環状キナゾリン誘導体 |
| US20030125268A1 (en) * | 2002-08-28 | 2003-07-03 | Rybak Mary Ellen Margaret | Farnesyl protein transferase inhibitor combinations with anti-tumor anthracycline derivatives |
| US7358259B2 (en) | 2003-09-26 | 2008-04-15 | Rigel Pharmaceuticals, Inc. | HCV inhibitors and methods of using them |
| WO2005089518A2 (en) * | 2004-03-18 | 2005-09-29 | The Brigham And Women's Hospital, Inc. | Uch-l1 expression and cancer therapy |
| SI2362218T1 (sl) | 2004-11-05 | 2014-12-31 | Janssen Pharmaceutica N.V. | Postopki za spremljanje učinkovitosti inhibitorjev farneziltransferaze |
| US20060194821A1 (en) * | 2005-02-18 | 2006-08-31 | The Brigham And Women's Hospital, Inc. | Compounds inhibiting the aggregation of superoxide dismutase-1 |
| US20060281755A1 (en) * | 2005-06-10 | 2006-12-14 | Baumann Christian A | Synergistic modulation of flt3 kinase using aminopyrimidines kinase modulators |
| US20060281769A1 (en) * | 2005-06-10 | 2006-12-14 | Baumann Christian A | Synergistic modulation of flt3 kinase using thienopyrimidine and thienopyridine kinase modulators |
| US20060281788A1 (en) | 2005-06-10 | 2006-12-14 | Baumann Christian A | Synergistic modulation of flt3 kinase using a flt3 inhibitor and a farnesyl transferase inhibitor |
| CA2634598A1 (en) | 2005-12-23 | 2007-07-05 | Link Medicine Corporation | Treatment of synucleinopathies |
| DE102006012545A1 (de) * | 2006-03-18 | 2007-09-27 | Sanofi-Aventis | Substituierte 2-Amino-4-phenyl-dihydrochinoline, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament, sowie sie enthaltendes Medikament |
| EP2021335B1 (en) * | 2006-04-20 | 2011-05-25 | Janssen Pharmaceutica N.V. | Heterocyclic compounds as inhibitors of c-fms kinase |
| US8697716B2 (en) | 2006-04-20 | 2014-04-15 | Janssen Pharmaceutica Nv | Method of inhibiting C-KIT kinase |
| EP2016070B1 (en) | 2006-04-20 | 2016-01-13 | Janssen Pharmaceutica N.V. | Inhibitors of c-fms kinase |
| JO3240B1 (ar) * | 2007-10-17 | 2018-03-08 | Janssen Pharmaceutica Nv | c-fms مثبطات كيناز |
| US8232402B2 (en) | 2008-03-12 | 2012-07-31 | Link Medicine Corporation | Quinolinone farnesyl transferase inhibitors for the treatment of synucleinopathies and other indications |
| AU2009313927A1 (en) | 2008-11-13 | 2010-05-20 | Astrazeneca Ab | Azaquinolinone derivatives and uses thereof |
| TW201329025A (zh) | 2011-11-01 | 2013-07-16 | Astex Therapeutics Ltd | 醫藥化合物 |
| RU2014136226A (ru) * | 2012-02-13 | 2016-04-10 | Ф.Хоффманн-Ля Рош Аг | Производные имидазолилкетона в качестве ингибиторов альдостеронсинтазы |
| JOP20180012A1 (ar) | 2012-08-07 | 2019-01-30 | Janssen Pharmaceutica Nv | عملية السلفنة باستخدام نونافلوروبوتانيسولفونيل فلوريد |
| IN2015DN00659A (cs) | 2012-08-07 | 2015-06-26 | Janssen Pharmaceutica Nv | |
| EA201590750A1 (ru) | 2012-10-16 | 2015-09-30 | Янссен Фармацевтика Нв | СВЯЗАННЫЕ С ФЕНИЛОМ ХИНОЛИНИЛОВЫЕ МОДУЛЯТОРЫ RORγT |
| PE20150778A1 (es) | 2012-10-16 | 2015-05-23 | Janssen Pharmaceutica Nv | Moduladores de quinolinilo unidos a metileno de ror-gamma-t |
| AU2013331493A1 (en) | 2012-10-16 | 2015-04-09 | Janssen Pharmaceutica Nv | Heteroaryl linked quinolinyl modulators of RORyt |
| US9221804B2 (en) | 2013-10-15 | 2015-12-29 | Janssen Pharmaceutica Nv | Secondary alcohol quinolinyl modulators of RORγt |
| EP3057421B1 (en) | 2013-10-15 | 2019-11-20 | Janssen Pharmaceutica NV | Alkyl linked quinolinyl modulators of ror(gamma)t |
| US10555941B2 (en) | 2013-10-15 | 2020-02-11 | Janssen Pharmaceutica Nv | Alkyl linked quinolinyl modulators of RORγt |
| US9403816B2 (en) | 2013-10-15 | 2016-08-02 | Janssen Pharmaceutica Nv | Phenyl linked quinolinyl modulators of RORγt |
| US9284308B2 (en) | 2013-10-15 | 2016-03-15 | Janssen Pharmaceutica Nv | Methylene linked quinolinyl modulators of RORγt |
| US9328095B2 (en) | 2013-10-15 | 2016-05-03 | Janssen Pharmaceutica Nv | Heteroaryl linked quinolinyl modulators of RORgammat |
| CN105848483A (zh) | 2013-10-15 | 2016-08-10 | 詹森药业有限公司 | RORγt 的喹啉基调节剂 |
| US11311519B2 (en) | 2014-05-01 | 2022-04-26 | Eiger Biopharmaceuticals, Inc. | Treatment of hepatitis delta virus infection |
| US10076512B2 (en) | 2014-05-01 | 2018-09-18 | Eiger Biopharmaceuticals, Inc. | Treatment of hepatitis delta virus infection |
| US20180338993A1 (en) * | 2014-12-04 | 2018-11-29 | Eiger Biopharmaceuticals, Inc. | Treatment of hepatitis delta virus infection |
| EP3285768B1 (en) | 2015-04-21 | 2020-12-30 | Eiger Biopharmaceuticals, Inc. | Pharmaceutical compositions comprising lonafarnib and ritonavir |
| ES2741782T3 (es) | 2015-08-17 | 2020-02-12 | Kura Oncology Inc | Métodos para tratar pacientes con cáncer a partir de inhibidores de la farnesiltransferasa |
| US10745370B2 (en) * | 2016-03-23 | 2020-08-18 | Mackay Memorial Hospital | Farnesyl transferase inhibitors and uses thereof |
| SG11201903786UA (en) | 2016-11-03 | 2019-05-30 | Kura Oncology Inc | Farnesyltransferase inhibitors for use in methods of treating cancer |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2002864C (en) | 1988-11-29 | 1999-11-16 | Eddy J. E. Freyne | (1h-azol-1-ylmethyl) substituted quinoline, quinazoline or quinoxaline derivatives |
| TW349948B (en) * | 1995-10-31 | 1999-01-11 | Janssen Pharmaceutica Nv | Farnesyl transferase inhibiting 2-quinolone derivatives |
| UA57717C2 (uk) * | 1995-12-08 | 2003-07-15 | Янссен Фармацевтика Н.В. | Похідні (імідазол-5-іл)метил-2-хінолінону, спосіб їх отримання та фармацевтична композиція на їх основі |
| TW591030B (en) * | 1997-03-10 | 2004-06-11 | Janssen Pharmaceutica Nv | Farnesyl transferase inhibiting 1,8-annelated quinolinone derivatives substituted with N- or C-linked imidazoles |
| ES2289783T3 (es) * | 1997-04-25 | 2008-02-01 | Janssen Pharmaceutica N.V. | Quinazolinonas que inhiben la farnesiltransferasa. |
| NZ501401A (en) * | 1997-06-02 | 2002-03-28 | Janssen Pharmaceutica Nv | (Imidazol-5-yl)methyl-2-quinolinone derivatives as inhibitors of smooth muscle cell proliferation |
-
1999
- 1999-12-17 CA CA2355717A patent/CA2355717C/en not_active Expired - Lifetime
- 1999-12-17 ID IDW00200101373A patent/ID29241A/id unknown
- 1999-12-17 HR HR20010454A patent/HRP20010454B1/xx not_active IP Right Cessation
- 1999-12-17 SI SI9930350T patent/SI1140935T1/xx unknown
- 1999-12-17 EP EP99969220A patent/EP1140935B1/en not_active Expired - Lifetime
- 1999-12-17 JP JP2000590995A patent/JP4725940B2/ja not_active Expired - Lifetime
- 1999-12-17 AU AU27953/00A patent/AU765437B2/en not_active Expired
- 1999-12-17 TW TW088122193A patent/TW531533B/zh not_active IP Right Cessation
- 1999-12-17 HK HK02100160.2A patent/HK1038746B/en not_active IP Right Cessation
- 1999-12-17 KR KR1020017006140A patent/KR100712226B1/ko not_active Expired - Lifetime
- 1999-12-17 CZ CZ20012142A patent/CZ302374B6/cs not_active IP Right Cessation
- 1999-12-17 IL IL14385999A patent/IL143859A0/xx active IP Right Grant
- 1999-12-17 KR KR1020067021243A patent/KR100818541B1/ko not_active Expired - Lifetime
- 1999-12-17 ES ES99969220T patent/ES2200591T3/es not_active Expired - Lifetime
- 1999-12-17 DE DE69907964T patent/DE69907964T2/de not_active Expired - Lifetime
- 1999-12-17 PT PT99969220T patent/PT1140935E/pt unknown
- 1999-12-17 US US09/868,992 patent/US6458800B1/en not_active Expired - Lifetime
- 1999-12-17 EE EEP200100318A patent/EE04962B1/xx unknown
- 1999-12-17 DK DK99969220T patent/DK1140935T3/da active
- 1999-12-17 AT AT99969220T patent/ATE240327T1/de active
- 1999-12-17 WO PCT/EP1999/010214 patent/WO2000039082A2/en not_active Ceased
- 1999-12-17 CN CNB99814763XA patent/CN1178938C/zh not_active Expired - Lifetime
- 1999-12-17 EA EA200100708A patent/EA004542B1/ru not_active IP Right Cessation
- 1999-12-17 SK SK873-2001A patent/SK286072B6/sk not_active IP Right Cessation
- 1999-12-17 PL PL349504A patent/PL199080B1/pl unknown
- 1999-12-17 UA UA2001064401A patent/UA71592C2/uk unknown
- 1999-12-17 BR BR9916827-8A patent/BR9916827A/pt not_active Application Discontinuation
- 1999-12-17 TR TR2001/01961T patent/TR200101961T2/xx unknown
- 1999-12-17 HU HU0104582A patent/HU229404B1/hu unknown
- 1999-12-22 AR ARP990106687A patent/AR021995A1/es active IP Right Grant
-
2001
- 2001-06-20 IL IL143859A patent/IL143859A/en not_active IP Right Cessation
- 2001-06-20 BG BG105631A patent/BG65124B1/bg unknown
- 2001-06-21 NO NO20013088A patent/NO318922B1/no not_active IP Right Cessation
- 2001-06-21 ZA ZA200105136A patent/ZA200105136B/en unknown
-
2002
- 2002-06-24 US US10/179,444 patent/US6914066B2/en not_active Expired - Lifetime
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ID29241A (id) | Turunan-turunan kinolin teranelasi-1,2 | |
| ATE435861T1 (de) | 12,13-cyclopropan-epothilonderivate | |
| NO2006016I1 (no) | 7,8,9,10-tetrahydro-6H-6,10-metanoazepinoÄ4,5-gÜkinoksalintartrat | |
| PT993456E (pt) | 4,5-diaril-imidazoles 2-substituidos | |
| CU23049A3 (es) | Dihidropirimidinas. | |
| ATE275151T1 (de) | 3,6-ketal-makrolidantibiotika | |
| IT1312540B1 (it) | Composto. | |
| ID28874A (id) | Inhibitor fosfodiesterase 4 turunan ftalazina. | |
| ID21413A (id) | Turunan-turunan 1,3,8,-triaza-spiro (4,5) dekan-4-on | |
| ID26909A (id) | Turunan-turunan 1,3,4-oksadiazolon | |
| DE60025958D1 (de) | 14,15-beta-methylen substituierte androgene | |
| ID28624A (id) | Turunan 2-fenilpiran-4-on | |
| ATE234839T1 (de) | 4,5-azolo-oxindole | |
| ID27686A (id) | Turunan 3-(2-okso-[1,3]bipirolidinil-3-ildenametil)-sefem | |
| DE69926606D1 (de) | Plazentaprotein 13 | |
| FI980759A0 (fi) | Taetningskonstruktion foer suglaodan i en sugvals | |
| ID26368A (id) | Turunan-turunan 2 deoksi higromisin | |
| DK1068200T3 (da) | 2,4,4-trisubstituerede-1,3-dioxolanfungicider | |
| ID24047A (id) | Turunan 5-tersubstitusi-3-oksaziazolil 1,6-naftiridin-2 1h-on | |
| DE69915055D1 (de) | Antitumorale 1,5-diazaanthraquinone | |
| DE69908923D1 (de) | 1,3,4-thiadiazolylazofarbstoffe-enthaltende tintenzusammensetzungen | |
| ES1041028Y (es) | Formulario de correspondencia. | |
| FI980743A0 (fi) | Gap-valsformare i en pappersmaskin | |
| FI980405A0 (fi) | Industriellt, kontinuerligt foerfarande foer framstaellning av "gravkalk" | |
| DZ2644A1 (fr) | Triazolo-Ä3,4-aÜ-pyridazine substituées en 1,2,4. |